Hydrophobicity at the surface of proteins

Proteins: Structure, Function and Genetics

Volumn 37, Issue 4, 1999, Pages 565-575

  Scarsi, Marco ^a   Majeux, Nicolas ^a   Caflisch, Amedeo ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Continuum electrostatics; Farnesyltransferase farnesylpyrophosphate; HoxB1 Pbx1; Hydrophobicity map; MDM2 p53; Molecular surface; P11 annexin II; Poisson equation; Solvent accessible surface; Thrombin NAPAP

Indexed keywords

ANNEXIN; FARNESYL TRANS TRANSFERASE; PARACETAMOL; PROTEIN; PROTEIN MDM2; PROTEIN P53; THROMBIN;

ARTICLE; BINDING SITE; CALCULATION; HYDROPHOBICITY; MOLECULAR DYNAMICS; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; STATISTICS; SURFACE PROPERTY;

ALKYL AND ARYL TRANSFERASES; ANNEXIN A2; BINDING SITES; DIPEPTIDES; DNA; DNA-BINDING PROTEINS; ELECTROSTATICS; FARNESYLTRANSTRANSFERASE; HOMEODOMAIN PROTEINS; MACROMOLECULAR SUBSTANCES; MODELS, MOLECULAR; NUCLEAR PROTEINS; PEPTIDES; PIPERIDINES; POLYISOPRENYL PHOSPHATES; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN STRUCTURE, QUATERNARY; PROTEINS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-MDM2; S100 PROTEINS; SURFACE PROPERTIES; THERMODYNAMICS; THROMBIN; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0032705825     PISSN: 08873585     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0134(19991201)37:4<565::AID-PROT7>3.0.CO;2-V     Document Type: Article

References (62)

1. Davis AM, Teague SJ. Hydrogen bonding, Hydrophobie interactions, and failure of the rigid receptor hypothesis. Angew Chem Int Ed 1999;38:736-749.
2. Janin J, Chothia C. The structure of protein-protein recognition sites. J Biol Chem 1990;265:16027-16030.
3. Janin J, Chothia C. Role of hydrophobicity in the binding of coenzymes. Biochemistry, 1978;17:2943-2948.
4. Horton N, Lewis M. Calculation of the free energy of association for protein complexes. Prot Sci 1992;1:169-181.
5. Young L, Jernigan RL, Covell DG. A role for surface hydrophobicity in protein-protein recognition. Prot Sci 1994;3:717-729.
6. Nicholls A, Sharp KA, Honig B. Protein folding and association: insights from the interfacial and thermodynamic properties of hydrocarbons. Proteins 1991;11:281-296.
7. Warwicker J, Watson HC. Calculation of the electric potential in the active site cleft due to α-helix dipoles. J Mol Biol 1982;157:671-679.
8. Gilson MK, Honig BH. Calculation of the total electrostatic energy of a macromolecular system: solvation energies, binding energies, and conformational analysis. Proteins 1988;4:7-18.
9. a's of ionizable groups in proteins: atomic detail from a continuum electrostatic model. Biochemistry 1990;29:10219-10225.
10. Davis ME, Madura JD, Luty BA, McCammon JA. Electrostatics and diffusion of molecules in solution: simulations with the University of Houston Brownian dynamics program. Comp Phys Comm 1991;62:187-197.
11. Majeux N, Scarsi M, Apostolakis J, Ehrhard C, Caflisch A. Exhaustive docking of molecular fragments on protein binding sites with electrostatic solvation. Proteins 1999;37:88-105.
12. Lee B, Richards FM. The interpretation of protein structures: estimation of static accessibility. J Mol Biol 1971;55:379-400.
13. Brooks BR, Bruccoleri RE, Olafson BD, States DJ, Swaminathan S, Karplus M. CHARMM: A program for macromolecular energy, minimization, and dynamics calculations. J Comput Chem 1983;4: 187-217.
14. Momany FA, Klimkowski VJ, Schäfer L. On the use of conformationally dependent geometry trends from ab initio dipeptide studies to refine potentials for the empirical force field CHARMM. J Comput Chem 1990;11:654-662.
15. Privalov PL, Gill SG. Stability of protein structure and hydrophobic interactions. Adv Prot Chem 1988;39:191-234.
16. Privalov PL, Gill SG. Common features of protein unfolding and dissolution of hydrophobic compounds. Adv Prot Chem 1990;247: 559-561.
17. Creighton TE. Stability of folded conformations. Curr Opin Struct Biol 1991;1:5-16.
18. Friedman RA, Honig B. A free energy analysis of nucleic acid base stacking in aqueous solution. Biophys J 1995;69:1528-1535.
19. Caflisch A, Fischer S, Karplus M. Docking by Monte Carlo minimization with a solvation correction: application to an FKBP-substrate complex. J Comput Chem 1997;18:723-743.
20. Vorobjev YN, Almagro JC, Hermans J. Discrimination between native and intentionally misfolded conformations of proteins: ES/IS, a new method for calculating conformational free energy that uses both dynamics simulations with an explicit solvent and an implicit solvent continuum model. Proteins 1998;32:399-413.
21. Still WC, Tempczyk A, Hawley RC, Hendrickson T. Semianalytical treatment of solvation for molecular mechanics and dynamics. J Am Chem Soc 1990;112:6127-6129.
22. Hawking GD, Cramer CJ, Trulhar DG. Pairwise solute descreening of solute charges from a dielectric medium. Chem Phys Lett 1995;246:122-129.
23. Hawkins GD, Cramer CJ, Trulhar DG. Parameterized models of aqueous free energies of solvation based on pairwise descreening of solute atomic charges from a dielectric medium. J Phys Chem 1996;100:19824-19839.
24. Schaefer M, Karplus M. A comprehensive analytical treatment of continuum electrostatics. J Phys Chem 1996;100:1578-1599.
25. Qiu DI, Shenkin PS, Hollinger FP, Still WC. The GB/SA continuum model for solvation. A fast analytical method for the calculation of approximate Born radii. J Phys Chem A 1997;101: 3005-3014.
26. Scarsi M, Apostolakis J, Caflisch A. Continuum electrostatic energies of macromolecules in aqueous solutions. J Phys Chem A 1997;101:8098-8106.
27. Scarsi M, Apostolakis J, Caflisch A. Comparison of a GB solvation model with explicit solvent simulations: potentials of mean force and conformational preferences of alanine dipeptide and 1,2-dichloroethane. J Phys Chem B 1998;102:3637-3641.
28. Jackson JD. Classical electrodynamics. John Wiley & Sons: New York; 1975.
29. Luo R, Moult J, Gilson MK. Dielectric screening treatment of electrostatic solvation. J Phys Chem B 1997;101:11226-11236.
30. Richards FM. Areas, volumes, packing, and protein structure. Ann Rev Biophys Bioeng 1977;6:151-176.
31. Hilpert K, Ackermann J, Banner DW et al. Design and synthesis of potent and highly selective thrombin inhibitors. J Med Chem 1994;37:3889-3901.
32. Bode W, Mayr I, Baumann U, Huber R, Stone SR, Hofsteenge J. The refined 1.9-Å crystal structure of human α-thrombin: interaction with D-Phe-Pro-Arg chloromethylketone and significance of the Tyr-Pro-Pro-Trp insertion segment. EMBO J 1989;8:3467-3475.
33. Banner DW, Hadvary P. Crystallographic analysis at 3.0-Å resolution of the binding to human thrombin of four active site-directed inhibitors. J Biol Chem 1991;266:20085-20093.
34. Obst U, Gramlich V, Diederich F, Weber L, Banner DW. Design neuartiger, nichtpeptidischer Thrombin-Inhibotoren und Struktur eines Thrombin-Inhibitoren-Komplexes. Angew Chem 1995; 107:1874-1877.
35. Håkansson K, Tulinsky A, Abelman MM, et al. Crystallographic structure of a peptidyl keto acid inhibitor and human α-thrombin. Bioorgan Med Chem 1995;3:1009-1017.
36. Brandstetter H, Turk D, Hoeffken HW, et al. Refined 2.3 Å x-ray structure of bovine thrombin complexes formed with the benzamidine and arginine-based thrombin inhibitors NAPAP, 4-TAPAP and MQPA. J Mol Biol 1992;226:1085-1099.
37. Buss JE, Marsters JC. Farnesyltransferase inhibitors: The successes and surprises of a new class of potential cancer chemotherapeutics. Chem Biol 1995;2:787-791.
38. Graham SL, Williams TM. Inhibitors of protein farnesylation. Exp Opin Ther Patents 1996;6:1295-1304.
39. Gibbs JB, Oliff A. The potential of farnesyltransferase inhibitors as cancer chemotherapeutics. Ann Rev Pharmacol Toxicol 1997;37: 143-166.
40. Long SB, Casey PJ. Beese LS. Cocrystal structure of protein farnesyltransferase complexed with a diphosphate substrate. Biochemistry 1998;37:9612-9618.
41. Momand J, Zambetti GP, Olson DC, George D, Levine AJ. The MDM-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell 1992;69:1237.
42. Russie PH, Gorina S, Marechal V, et al. Structure of the MDM2 oncoprotein bound to the p53 tumor suppressor transactivation domain. Science 1996;274:948-953.
43. Gehring WJ, Affolter M, Bürglin T. Homeodomain proteins. Ann Rev Biochem 1994;63:487-526.
44. McGinnis W, Krumlauf R. Homeobox genes and axial patterning. Cell 1992;68:283-302.
45. Piper DE, Batchelor AH, Chang CP, Cleary ML, Wolberger C. Structure of a HoxB1-Pbx1 heterodimer bound to DNA: role of the hexapeptide and a fourth homeodomain helix in complex formation. Cell 1999;96:587-597.
46. Kligman D, Hilt DC. The S100 protein family. Trends Biochem Sci 1988;13:437-443.
47. Gerke V, Weber K. The regulatory chain of the p36-kd substrate complex of viral tyrosine-specific protein kinases is related in sequence to the s-100 protein of glial cells. EMBO J 1985;4:2917-2910.
48. Waisman DM. Annexin II tetramer:structure and function. Mol Cell Biochem 1995;149/150:301-322.
49. Gerke V, Moss S. Annexins and membrane dynamics. Biochim Biophys Acta 1997;1357:129-154.
50. v-src. Biochem J 1987;247:321-328.
51. Rety S, Sopkova J, Renouard M, et al. Crystal structure of a complex of p11, the ligand of annexin II, with the annexin II N-terminal peptide. Nature Struct Biol 1999;6:89-95.
52. Rasmussen R, Benvegnu D, O'Shea EK, Kim PS, Alber T. X-ray scattering indicates that the leucine zipper is a coiled coil. Proc Natl Acad Sci USA 1991;88:561.
53. O'Shea EK, Rutkowski R, Kim PS. Evidence that the leucine zipper is a coiled coil. Science 1989;243:538-542.
54. Arevalo JH, Stura EA, Taussig MJ, Wilson IA. Three-dimensional structure of an anti-steroid Fab' and progesterone-Fab' complex. J Mol Biol 1993;231:103-118.
55. Langedijk AC, Spinelli S, Anguille C, et al. Insight into odorant perception: the crystal structure and binding characteristics of antibody fragments against the musk odorant traseolide. J Mol Biol 1999:in press.
56. Mittl PRE, Di Marco S, Fendrich G, et al. A new structural class of serine protease inhibitors revealed by the structure of the hirustasin-kallikrein complex. Structure 1996;5:253-264.
57. Fitzgerald PMD, McKeever BM, VanMiddlesworth JF, et al. Crystallographic analysis of a complex between human immunodeficiency virus type 1 and acetyl-pepstatin at 2.0 Åresolution. J Biol Chem 1990;265:14209-14219.
58. Sánchez R, Šali A. Large-scale protein structure modeling of the Saccharomyces cerevisiae genome. Proc Natl Acad Sci USA 1998; 95:13597-13602.
59. Davis ME, McCammon JA. Solving the finite difference linearized Poisson-Boltzmann equation: a comparison of relaxation and conjugate gradient methods. J Comput Chem 1989;10:386-391.
60. Davis ME, McCammon JA. Calculating electrostatic forces from grid-calculated potentials. J Comput Chem 1990;11:401-409.
61. Davis ME, McCammon JA. Dielectric boundary smoothing in finite difference solutions of the Poisson equation: An approach to improve accuracy and convergence. J Comput Chem 1991;12:909-912.
62. Strickland CL, Windsor WT, Syto R, Wang L, Bond R, Wu Z, Schwartz J, Le HV, Beese LS, Weber PC. Crystal structure of farnesyl protein transferase complexed with a CaaX peptide and farnesyl diphosphate analogue. Biochemistry 1998;37:16601-16611.